Global Biologics Consulting Services Market is poised to witness a CAGR of >15%, driven by the Growing VC Fundings and Investments for Biologics & Increasing Biologics Regulatory Approvals

While small molecules are either made synthetically or purified from plants, biologics are medicines which are made from living cells. Although small molecules comprise >90% of drugs, pharmaceutical and biotechnological companies are shifting their focus to manufacturing and developing profitable biologics drugs.

Complex Nature of Biologics & its Growing Importance is driving the Biologics Consulting Services Market

Compared to small molecules, biologics are large, highly complex, heterogeneous molecules, more expensive, sensitive to external conditions and need to go through complex manufacturing processes and have stringent regulatory requirements, thus requiring a higher level of expertise.

With the increasingly complex and significantly evolving biopharmaceutical industry, companies are looking for consultancies which are able to provide regulatory leadership, product development consulting, and an expertise in all stages from early-stage drug discovery to commercialization. Moreover, the growing importance of new biologics drugs is seen over the last few years, with biologics contributing to 25% of new molecule approvals in USA in 2020. This further boosts the demand for biologics consulting services.

"Recent development of blockbuster biologics (antibody, immunosuppressants, anticancer, atopic dermatitis), growing number of biosimilars being approved as patents continue to die, the entrance of small, virtual pharmaceutical startups in the market with no manufacturing capacity and/or limited development expertise, and growing prevalence of chronic infectious diseases & cancer are some of the primary factors likely to drive the biologics consulting services market."-Head of Process Development, Leading Biologics Consulting Company, USA

Growing Influx of Small Biotech Companies Lacking Manufacturing OR Development Expertise

With the growing demand for novel therapies, there is a growing influx of small biotech companies which lack in-house capabilities and expertise. These firms are over reliant on biologics consulting companies for end-to-end services from the exploratory phase to commercial manufacturing. Nevertheless, big biopharmaceutical companies need to work in a complex and dynamic environment which requires strict attention to meeting new regulatory standards. They also approach consulting firms to help them to maintain a strong track record of quality, compliance, and regulatory expertise.

Increasing Demand for Advanced Biologics Consulting Services

Advanced therapies, such as cell and gene therapies and personalized vaccines require specialized expertise throughout the development, manufacturing, and regulatory process. Newer vaccine technologies like viral vector and mRNA where demand exceeds supply and capabilities/technical expertise may not exist even in large biopharmaceutical firms. Moreover, the rapidly evolving regulatory landscape makes it very essential to have an up-to-date knowledge and expertise to successfully develop a product and gain a centralized market authorization (MA) in Europe and/or a Biologic License Authorization (BLA) in USA. With an increasingly growing demand for advanced biologics therapies, there is a corresponding demand for biologics consulting services.

Geographic Analysis: North America Leads the Adoption of Biologics Consulting Services Market

From a geographical perspective, North America holds the larger share of the biologics consulting services market. This is mainly attributed to an emerging biopharmaceutical industry, favorable government policies supporting biologics innovation, the presence of leading biologics consulting firms, significant R&D spending in USA, strict FDA regulations, and a greater focus on advanced therapies.

Competitive Landscape Analysis: Biologics Consulting Services Market

The global biologics consulting services market is highly competitive and fragmented. Some of the established and emerging players operating in this global market are IQVIA, NNE, ProductLife Group, Clarkston Consulting, Fingerpaint, Azenta Life Sciences, Biologics Consulting Group, UDG Healthcare, ProPharma Group, APCER Life Sciences, Freyr Solutions, ADVANCED CELL & GENE THERAPY, LLC, Dark Horse Consulting, and eXmoor pharma concepts limited.

Get Detailed Insights on Biologics Consulting Services Market with a Sample Redacted Deck @ https://meditechinsights.com/biologics-consulting-services-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.